| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $104.76M | - | |
| Dir | 1.55M | $82.82M | - | |
| Dir | 1.19M | $63.41M | - | |
| CFO | 1.12M | $59.58M | - | |
| VP | 594.7K | $31.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 30, 2018 | Feldbaum Carl B47 | Director | Sale+OE | 34,262 | $20.60 | $705,797.20 | -69.2% | |
| May 24, 2018 | Morrissey Michael | President And CEO | Sale+OE | 90,000 | $20.55 | $1,849,500.00 | -41.9% | |
| May 22, 2018 | Willsey Lance | Director | Sell | 50,000 | $21.40 | $1,070,000.00 | -10.7% | |
| May 18, 2018 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sell | 3,663 | $21.61 | $79,157.43 | -2.8% | |
| May 11, 2018 | Marchesi Vincent T | Director | Sale+OE | 15,000 | $19.03 | $285,450.00 | -10.6% | |
| May 9, 2018 | Cohen Charles | Director | Sale+OE | 15,000 | $21.42 | $321,300.00 | -5.7% | |
| May 7, 2018 | Papadopoulos Stelios53 | Director | Sale+OE | 15,000 | $22.15 | $332,250.00 | -1.4% | |
| May 7, 2018 | Haley Patrick J.56 | Sr. Vice President, Commercial | Sale+OE | 27,549 | $22.17 | $610,846.62 | -9.5% | |
| May 4, 2018 | Hessekiel Jeffrey54 | EVP And General Counsel | Sell | 20,000 | $22.36 | $447,200.00 | -5.9% | |
| May 3, 2018 | Schwab Gisela67 | Pres Prod Dev &Med Aff &CMO | Sale+OE | 22,500 | $23.09 | $519,417.00 | -3.8% |